Advertisement

Topics

Companies Related to "Global Development secures future drug candidate development CollegeHill" [Most Relevant Company Matches] - Page: 4 RSS

11:17 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Global Development secures future drug candidate development CollegeHill" found in our extensive corporate database of over 50,000 company records.

Showing "Global Development secures future drug candidate development CollegeHill" Companies 76–100 of 13,000+

Relevant

Saitama Daiichi Pharmaceutical Co., Ltd.

Since the founding of our company in 1963, we have steadily advanced in the areas of research and development and production, in the sincere pursuit of people's health. In this quest, we have become an industry leader in the research, development and production of ointments and liquid preparations, working diligently to meet ever-growing expectations. Some of our success stories include the ethica...


ADC Therapeutics Sarl

ADC Therapeutics (ADCT) is a Swiss-based oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers such as breast lung, prostate, renal and blood. The Company’s ADCs are highly targeted drug constructs which combine monoclonal antibodies specific to particular types of ...

Pharmaceutical Product Development

As a leading global provider of discovery and development services and products for pharmaceutical and biotechnology companies, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients maximize the return on their R&D investments. With proven early discovery through post-market resources, the company also offers unique partnerships and alliances for vi...


Adeona Pharmaceuticals, Inc.

Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Adeona's primary strategy is to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to an inflection point in valuation resulting in a significant development and marketing collaboration. Trimesta (estriol) ...

VistaGen Therapeutics, Inc

VistaGen Therapeutics is a biopharmaceutical company developing breakthrough drugs for disorders of the Central Nervous System (CNS) and diabetes. Our lead drug candidate AV-101 targets two large CNS markets epilepsy and neuropathic pain. Our key R&D partnership applies our clinically predictive in vitro embryonic stem cell technologies to discover and develop a new generation of drug candidates f...

Vividion Therapeutics, Inc.

Conventional drug discovery is target-centric; a compound library is screened using a target-specific assay and high-affinity binding ligands are optimized to develop a drug candidate. This approach is limited, as research is performed in artificial systems that fail to account for native protein structure, context and function. Further, conventional targe...

Zymeworks Inc. and LEO Pharma

Zymeworks is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics. Zymeworks’ suite of complementary therapeutic platforms and its fully-integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop h...

Boston Strategics Corporation (BSC)

BSC is an integrated drug R&D company with experience in developing, managing and optimizing global drug development programs from late discovery, through translational research, first-in-man and proof-of-concept studies. Its mission is to continuously improve patient health care by changing the drug R&D paradigm using “True” Open Innovationâ...

Cureline, Inc

Cureline is a global biosample management company providing effective solutions for human tissue acquisition and related histology services. It was founded by a group of scientists and business development professionals who established the biorepository for SUGEN and participated in the development of Sutent (Pfizer Inc). Cureline has developed multinational collaborations and has implemented pro...

Deciphera Pharmaceuticals, LLC

Deciphera Pharmaceuticals is a drug discovery and development company whose objective is to design, optimize, and introduce small molecule therapeutics for human clinical trials and the global pharmaceutical marketplace. The company business focuses on the development of small molecule drug candidates which correct the molecular basis of human disease by regulating protein shape.

New Medicine

NEW MEDICINE maintains the most comprehensive electronic resource in the cancer field. The ONCOLOGY KNOWLEDGEBASE (nm/OK) is a resource ,accessible via the world wide web, that covers all aspects of drug development in cancer.We also publish the premier analytical newsletter in cancer, FUTURE ONCOLOGY. It is a monthly newsletter analyzing the latest developments in the epidemiology, diagnosis, a...

SolarReserve

SolarReserve is a leading global renewable infrastructure developer of solar power projects, which include electricity generation by solar thermal energy with energy storage, as well as photovoltaic panels. The deployment of these renewable technologies brings additional benefits to global economies through job creation, greater energy security, and a more...

ContraVir Pharmaceuticals, Inc.

“ContraVir’s recent emergence as a public company requires a unique individual who combines leadership skills with extensive experience in antivirals to spearhead ContraVir’s future development," said Gary S. Jacob, Board Chairman of ContraVir. “James Sapirstein is just that individual. James has actively led and participated in more than 20 ...

PharmaNet Incorporated

PharmaNet is a full-service contract research organization (CRO) dedicated to providing exceptional drug development services on a global basis. With offices strategically placed throughout the US, Europe and Asia, we provide a complete range of Phase I-IV clinical development services including strategic planning, data management and biostatistics, medical writing, site management and regulatory ...

Furiex Pharmaceuticals, Inc.

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by advancing them through the drug discovery and development process in a cost-efficient manner. Development programs are designed and driven by a core team with extensive drug development ...

Neurochem

Neurochem Inc. is a dynamic, highly energized biopharmaceutical company with an exciting vision and future, located in the Parc scientifique et de haute technologie de Laval, in Quebec, Canada.Neurochem's strategic plan focuses on the further development of a strong, steadily expanding pipeline of product candidates addressing vital unmet medical needs. These products focus primarily on neurologic...

Synergy Pharmaceuticals Inc.

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of new drugs to treat patients with gastrointestinal (GI) diseases and disorders. Synergy’s lead drug, plecanatide, and next generation candidate, SP-333, are proprietary analogs of the natural human GI hormone, uroguanylin, and members of the new class of guanylate ...

Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. Our next-generation URAT1 inhib...

Partners for Development investments in Life Sciences, P.U.L.S. AB

Partners for Development investments in Life Sciences, P.U.L.S. AB (PULS) was founded in 2002. PULS acts as an incubator and investor for early projects within life science, mostly drug development, and has started nine project companies. PULS consist of an operational management team and more than 30 partners with long experience in life sciences and competence through the whole value chain, ...

Tularik Incorporated

We have developed a drug discovery and development infrastructure that we believe positions us to become a leading pharmaceutical company. Our drug discovery and development expertise includes molecular biology, biochemistry, structural biology, chemistry, pharmacology and human testing. Our management team has extensive drug discovery and development experience with large pharmaceutical companies...

Achillion Pharmaceuticals

Achillion is a privately held pharmaceutical company focused on the discovery, development and commercialization of innovative small molecule drugs that combat drug resistance in infectious diseases, with a particular emphasis on antiviral drugs to treat diseases caused by hepatitis B and C viruses (HBV and HCV), HIV and herpes viruses.Product Candidate PortfolioThe Company’s broad drug developm...

Strategia Holdings, LLC

Strategia Holdings, LLC, is based in the U.S. and oversees three biotech companies; Spirita Oncology, LLC, Mirata BioPharma, LLC, and Strategia Pharmaceuticals, LLC. Spirita focuses on oncology drug development in the US with E6201, a MEK1 inhibitor, as their flagship candidate focused on melanoma brain metastases. Mirata is a pre-clinical stage immuno-onc...

AKOS Healthcare Group Ltd

AKOS is an established Regulatory Affairs and Development service company, offering global support and consultancy in the development of medicinal products. We are based in the United Kingdom and operate extensively throughout Continental Europe. Our experienced staff support development projects from laboratory to marketing, via pre-clinical and manufacturing to proof-of-principle clinical studie...

Terns Pharmaceuticals Inc.

Based in San Mateo, CA., and Shanghai, China, Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly targeted, oral, small molecule drugs to treat liver disease and cancer. The company combines expertise in disease biology, medicinal chemistry and extensive clinical development capabilities in China to ...

APR APR Applied Pharma Research s.a.

APR is a Swiss independent pharma company focused on development and commercialization of innovative, science-driven products designed to address unmet needs in niche or rare therapeutic areas on a global basis. APR combines drug development expertise with proprietary drug delivery technologies to deliver to patients suffering from rare diseases with solut...


More From BioPortfolio on "Global Development secures future drug candidate development CollegeHill"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks